RECCE-529

N/A

Report date: 2024/12/16 10:19:45
NME

Base Information

Drug NameRECCE-529
Drug Alias NameR529RECCE-529
ClassificationSmall molecules > Polymers and chelators
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRecce Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRecce Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A